Effects of the inhalational anesthetics halothane and sevoflurane on an experimental model of hepatic injury;O Efeito dos Anestésicos Inalatórios Halotano e Sevoflurano em um Modelo Experimental de Lesão Hepática

Revista Brasileira de Anestesiologia

Volumn 61, Issue 5, 2011, Pages 591-603

  Soubhia, Andrea Fogaça ^a   Lauz, Susi ^a   Montero, Edna Frasson de Souza ^b   Menezes, Alessandro ^a   Mespaque, Luciane Bicca ^a   Facin, Emilio ^a  

^a FURG   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

General Anesthesia; Halothane; Hepatopathies; Inhalational Anesthetics

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HALOTHANE; PHENOBARBITAL; SEVOFLURANE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL MODEL; INFLAMMATORY INFILTRATE; LIVER INJURY; LIVER NECROSIS; MALE; MICROSCOPY; NONHUMAN; RAT; STEATOSIS;

ANESTHETICS, INHALATION; ANIMALS; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; HALOTHANE; MALE; METHYL ETHERS; RATS; RATS, WISTAR;

EID: 80053065803     PISSN: 00347094     EISSN: 1806907X     Source Type: Journal    
DOI: 10.1016/S0034-7094(11)70070-8     Document Type: Article

References (15)

1. Powell-Jackson P., Greenway B., William R. Adverse effects of exploratory laparotomy in patients with unsuspected liver disease. Br J Anesth 1982, 69:449-451.
2. Garrison R.N., Cryer H.M., Howard D.A., Polk H.C. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984, 199:648-655.
3. McLain G.E., Sipes I.G., Brown B.R. An animal model of halothane hepatotoxicity: roles of enzyme induction of hypoxia. Anesthesiology 1979, 51:321-326.
4. Shingu K., Eger E.I., Johnson B.H., et al. Hepatic injury induced by anesthetic agents in rats. Anesth Analg 1983, 62:140-145.
5. Ray D.C., Drumond G.B. Halothane hepatitis. Br J Anesth 1991, 67:84-99.
6. Martin J., Dubbink D.A., Plevak D.J., et al. Halothane hepatitis 28 years after primary exposure. Anesth Analgesia 1992, 74:605-608.
7. Fassoulaki A., Eger E.I., Johnson B., et al. Brief periods of hypoxia can produce hepatic injury in rats. Anesth Analg 1984, 63:885-887.
8. Mets B., James M., James M.F., Hickman R. Hepatic energy charge and adenine nucleotide status in rats anesthetized with halothane, isoflurane or enflurane. Acta Anesth Scand 1997, 41:252-255.
9. Njoku D., Laster M., Eger E. Biotransformation of halothane, enflurane, isoflurane and desflurane to trifluoroacetylated liver protein: association between protein acylation and hepatic injury. Anesth Analg 1997, 84:173-178.
10. Soma L.R., Tierney W.J., Hogan G.K., Satoh N. The effects of multiple administrations of sevoflurane to monkeys: clinical pathologic, hematologic and pathologic study. Anesth Analg 1995, 81:347-352.
11. Kharasch E.D. Metabolism and toxicity of the new anesthetic agents. Acta Anesthesiol Belg 1996, 47:7-14.
12. Frink E.J. The hepatic effects of sevoflurane. Anesth Analgesia 1995, 81:46-50.
13. Brasil L.J., Amaral J.L., Zettler C.G., Marroni C.A., Vercelino R., Marroni N. Modelo experimental de indução de lesão oxidativa hepática em ratos por halotano. Arq Gastroenterol 2007, 44:45-51.
14. Nagata R., Sameschima H., Komaki T., et al. The effects of inhalation of sevoflurane for an hour on the liver of beagles. Jap J Anesth 1991, 40:887-895.
15. Wallin R.F., Regan B.M., Napoli M.D., Stern I.J. Sevoflurane: a new inhalation anesthetic agent. Anesth Analgesia 1975, 54:758-766.